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Abstract We have isolated a cDNA encoding a precursor of
dermorphin from the skin of Pachymedusa dacnicolor. Besides
four copies of this opioid peptide, the deduced sequence also
contains the genetic information for a novel peptide Tyr-Ile-Phe-
His-Leu-Met-Asp-NH2. This differs from Met-deltorphin by the
presence of Ile at position 2. In a related precursor from the skin
of Agalychnis annae, the sequence of this peptide is in the
3P-untranslated region of the cloned cDNA. From earlier results
we predict that in skin peptides the second residue is D-allo-Ile.
We have synthesized this and related peptides with different D-
amino acids, and determined their N agonist activity. The peptide
with D-nor-Leu binds with high affinity to N receptors, while that
with D-allo-Ile is about 100 times less active.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Numerous peptides have been isolated from the skin of
frogs belonging to the subfamily Phyllomedusinae [1,2]. Of
particular interest are a group of opioid peptides, dermor-
phins and deltorphins, which all contain a D-amino acid at
the second position [3]. By a combination of peptide isolation,
pharmacological tests and cDNA cloning, more than half a
dozen such peptides have been characterized. The dermor-
phins and deltorphins mostly have high a⁄nity and selectivity
for W or N opioid receptors, respectively.
The subfamily of Phyllomedusinae has been divided further
into three groups, the Phyllomedusa, the Agalychnis and one
Pachymedusa species [4]. In previous studies, only a few of the
more than 30 Phyllomedusa species have been investigated. In
addition, dermorphin has been isolated from skin extracts of
Agalychnis callydrias [5]. In an attempt to search for new
opioid peptides, we have studied two additional species, Pa-
chymedusa dacnicolor and Agalychnis annae. We have
searched cDNA libraries prepared from skin of these two
species using sequence information from cDNAs encoding
dermorphin and deltorphin precursors from Ph. sauvagei
and Ph. bicolor [6,7]. Here we describe a new deltorphin pre-
dicted from cDNA sequences. We also present the biological
activity of this new peptide and some of its relatives.
2. Materials and methods
2.1. Frogs, materials
A. annae from Costa Rica and P. dacnicolor from Southern Mexico
were bred in captivity by Christian Proy (Vienna). Synthetic peptides
were obtained from Dr. R. Frank (University of Heidelberg).
2.2. RNA preparation and cDNA synthesis
Frog skin was immediately frozen on dry ice and stored at 370‡C.
Total RNA was isolated using guanidinium thiocyanate [8] as de-
scribed [6]. First strand cDNA was synthesized with 5 Wg total
RNA using the primer adaptor GGAATTCTCGAGCTCAAGC(T18)
and reverse transcriptase (Superscript RNase H3, Gibco-BRL) as
recommended by the supplier. The second strand was synthesized
with polymerase I and RNase H (Boehringer Mannheim) [9]. After
blunt ending, double stranded adaptors were ligated to the cDNA
(Marathon cDNA Ampli¢cation Kit, Clontech Laboratories). The
reaction mixture was diluted 1:50 with water and stored at 320‡C.
2.3. Ampli¢cation of cDNA ends and sequence analysis
PCR ampli¢cation was performed using the degenerate sense and
antisense primers derived from the sequence encoding dermorphin
(YAFGYPS) [6]. For the 3P-RACE protocol, the downstream gene
speci¢c primer and Ada-4 (hybridizing to the cDNA synthesis primer
Ada-3) were used. The 5P-RACE was performed with the upstream
core primer and AP-1 (hybridizing to the marathon adaptor). Cycling
parameters for ampli¢cation of adaptor ligated cDNAs were accord-
ing to Chenchik et al. [10].
Ampli¢ed fragments were subcloned into the pBluescript II vector
(Stratagene). Sequencing reactions were performed with the thermo-
sequenase kit (Amersham) and IRD-41 £uorescent labeled primers
(MWG Biotech) and afterwards analyzed on a LI-COR automated
DNA sequencer 4000 (MWG Biotech). Only cDNAs that were iden-
tical in at least two separate PCR experiments were used for further
characterization. DNA sequences were deposited in the EMBL data
base (accession numbers for AJ005443: Pachymedusa dacnicolor
mRNA for opioid peptide; and AJ005444: Agalychnis annae
mRNA for opioid peptide, partial.)
2.4. Pharmacological tests
The biological activity of di¡erent peptides was tested on isolated
preparations of electrically stimulated mouse vas deference (MVD)
and guinea pig ileum (GPI) that are rich in N and W opioid receptors,
respectively [11]. Agonists were evaluated for their ability to inhibit
the electrically evoked twitch. The results were expressed as IC50 val-
ues obtained from concentration-response curves [12]. Values are ex-
pressed as mean þ S.E.M. from at least ¢ve tissues samples.
Binding of peptides to N, W, and U opioid receptors was assayed on
crude membranes from rat brain, guinea pig brain, and cell lines as
described previously [11].The N binding sites were labeled with [3H][D-
Ala2,Asp4]deltorphin (deltorphin I, 0.3 nM) on rat brain membranes
and with [3H][D-Ala2,Glu4]deltorphin (deltorphin II, 0.3 nM) on
NG-108/15 cells (a murine neuroblastomaUglioma hybrid cell line
which expresses high levels of N receptors) and CHO cells which
had been transfected with the cloned mouse N opioid receptor [13].
The W sites were labeled with [3H][D-Ala2,MePhe4,Glyol5]enkephalin
([3H]DAGO, 0.5 nM) in rat brain. The U sites were labeled with
[3H]U-69,593 (1 nM) in guinea pig brain. Competition curves were
determined in triplicate. The inhibition constant (Ki) of the various
peptides was calculated from the curves with the computer program
Ligand [14]. Data obtained from three independent measurements are
presented as the arithmetic mean þ S.E.M.
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3. Results
The precursors for dermorphins and deltorphins all contain
several copies of the mature peptides [6,7]. This was also
found to be the case for P. dacnicolor and A. annae. The
amino acid sequence of a precursor as deduced from a
cDNA cloned from skin of P. dacnicolor is shown in Fig.
1A. This precursor starts with a putative signal peptide and
then contains four copies of dermorphin separated by almost
identical spacer peptides. Close to the carboxyl end, the se-
quence of a novel peptide is present. Flanked by the same type
of sequences as the dermorphin copies, this peptide has the
structure Tyr-Ile-Phe-His-Leu-Met-Asp. Except for the Ile in
position 2, this peptide is identical to Met-deltorphin, which
was also originally predicted from the sequence of a cloned
cDNA [7] and subsequently isolated from skin extracts [15^
17].
A cDNA encoding a fragment of a related precursor could
be isolated from skin of A. annae (Fig. 1B). In the common
region the nucleotide and the deduced polypeptide sequence
are about 80% identical. However, three in-frame codons are
present after the last dermorphin copy. Consequently, the
conserved sequence of the peptide related to Met-deltorphin
is now located in the 3P-untranslated region of the mRNA
encoding the A. annae precursor.
Opioid peptides from Phyllomedusa skin all contain a D-
amino acid at the second position, which is derived from
the corresponding L-form in the precursor. In the case of L-
isoleucine, a change of chirality of the K carbon yields D-allo-
isoleucine (D-aIle). This amino acid has indeed been detected
in peptides from skin of Bombina variegata [18]. It can thus be
assumed that the peptide predicted from the cloned cDNAs
has the amino-terminal sequence Tyr-D-aIle-Phe.
We have tested several synthetic homologous of Met-deltor-
phin which contained either D-allo-isoleucine, D-leucine, D-
norleucine (D-nLeu) or D-valine as the second amino acid.
The potency, the receptor a⁄nity and selectivity of these pep-
tides have been measured by bioassays on isolated organ
preparations and by binding to crude membrane preparations
(Table 1). In MVD preparations, the peptide with D-nLeu
(IC50 = 0.76 þ 0.1 nM) was about three times more active
than Met-deltorphin (IC50 = 2.5 þ 0.3 nM); conversely, the
IC50 for the putative natural peptide with D-aIle was about
30 times higher (70 þ 8.2 nM). In GPI preparations, depres-
sion of twitch was obtained in the micromolar range, i.e. at
about 1000 times higher concentrations.
Similar results were obtained in binding studies using crude
rat brain membranes. The order of a⁄nity for the N receptor,
measured as inhibition constant (Ki) of [3H]deltorphin I bind-
ing, was D-nLeusD-MetsD-IlesD-ValsD-aIle (see Table
1). However, the N/W selectivity obtained in these binding ex-
periments was generally about one order of magnitude lower
than the MVD/GPI potency ratio.
Binding studies were also performed using NG108-15 cells
and CHO cells transfected with the N receptor. [3H]Deltorphin
II bound to these cells was displaced by some of these pep-
tides as shown in Table 2. The peptides tested displayed high-
er a⁄nity for the N receptor on NG108-15 cells than for the
cloned receptor.
All the compounds had no a⁄nity for the U receptors
(Kis 10 WM, data not shown).
4. Discussion
The precursors of opioid peptides from Phyllomedusinae
contain several copies of the end-products in their sequence.
However, these are arranged in di¡erent orders. In case of the
dermorphin precursor from Ph. sauvagei, the Met-deltorphin
is ¢rst followed by four copies of dermorphin. Conversely, as
shown in this communication, in P. dacnicolor the Ile-deltor-
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Fig. 1. Amino acid sequences deduced from cloned cDNAs from
skin of Pachymedusa dacnicolor (A) and Agalychnis annae (B). Der-
morphin sequences are underlined, the new peptide is double under-
lined. The end of the signal peptide is marked by an arrow, gaps to
maximize internal similarities by dashes (-), stop codons by slashes
(/). In the Agalychnis sequence, an insertion with two in-frame stop
codons is present.
Table 1
Pharmacological activities of Met-deltorphin and analogs
Peptide IC50 (nM) Ki (nM)
MVD GPI MVD/GPI N rec W rec N/W
D-Met 2.5 þ 0.3 1700 þ 200 1.4U1033 9.6 þ 1.9 1630 þ 59 5.9U1033
D-aIle 70 þ 8.2 3200 þ 307 2.2U1032 54 þ 6.5 452 þ 68 1.2U1031
D-Ile 7.0 þ 0.9 4200 þ 375 1.7U1033 24 þ 3 1021 þ 157 2.3U1032
D-nLeu 0.76 þ 0.1 730 þ 63 1.0U1033 3.8 þ 0.8 314 þ 37 1.2U1032
D-Val 12.3 þ 1.5 750 þ 71 1.6U1032 34 þ 4.1 293 þ 35 1.1U1031
Peptides tested had the sequence Tyr-D-Xaa-Phe-His-Leu-Met-Asp-NH2. The amino acid present in the second position is indicated in the ¢rst
column. IC50 : agonist concentrations that produced 50% inhibition of the electrically evoked twitch; Ki : equilibrium dissociation constant of the
competing ligand. The N receptors were labeled with 0.3 nM [3H]deltorphin I, the W receptors with 0.5 nM [3H]DAGO
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phin is last, near the carboxyl end. However, all these precur-
sors are closely related to each other. In a phylogenetic tree
constructed from the 3P-ends of these precursors, the related-
ness mirrors the geographic distribution of the four species. P.
dacnicolor from Southern Mexico and A. annae from Costa
Rico form one closely related pair, P. bicolor from Amazonia
and P. sauvagei from Argentina a second one.
Besides dermorphin, the two species investigated apparently
contain only one additional opioid peptide which closely re-
sembles Met-deltorphin. The natural compound which should
contain D-aIle at the second position is a deltorphin. How-
ever, its a⁄nity and selectivity for N receptors is considerably
lower than that of Met-deltorphin.
For comparison, we have also tested a number of related
peptides which only di¡er from Met-deltorphin by the nature
of the D-amino acid at position 2. Among these, the norleu-
cine analog displays the highest a⁄nity for N receptors. Some
of these peptides elicit unusual behavioral traits when injected
into the brain of rats. These e¡ects are currently under inves-
tigation.
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Table 2
Inhibition constants of [3H]deltorphin II (0.3 nM) binding to cells
Peptide Ki (nM)
NG 108-15 CHO-d
D-Met 8.1 þ 0.7 17.8 þ 1.9
D-Ile 12.8 þ 1.5 43.2 þ 5.1
D-aIle 36.1 þ 4.2 118 þ 20
Met-deltorphin and two analogs with di¡erent residues at the second
position were tested.
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